Adage Capital Partners Gp, L.L.C. Immunic, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Immunic, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,398,600 shares of IMUX stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,398,600
Previous 5,594,406
75.0%
Holding current value
$1.65 Million
Previous $9.23 Million
84.85%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
51.2MCall Options Held
824KPut Options Held
354K-
Bvf Inc San Francisco, CA8.9MShares$10.5 Million0.33% of portfolio
-
Avidity Partners Management LP Dallas, TX7.97MShares$9.4 Million0.9% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$8.61 Million0.51% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$5.39 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.92MShares$4.63 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $36.1M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...